Evidence map›Paper›PMID 38611878›Full record

ArticleMolecules (Basel, Switzerland)2024

Establishing

Shuya Zhang, Jiaxuan Xia, Ying Zhu, Meichen Dong, Jianxin Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Extracellular vesicles and circulating nucleic acids · 2026
    Article
  6. Article
  7. Mediators of inflammation · 2026
    Article
  8. Review
  9. Evaluation ofInternational journal of nanomedicine · 2026
    Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Nanomedicine (London, England) · 2025
    Article
  16. Review
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shuya ZhangDepartment of Pharmaceutics, School of Pharmacy, Fudan University & Key Laboratory of Smart Drug Delivery, Ministry of Education, MOE Innovative Center for New Drug Development of Immune Inflammatory Diseases, Fudan University, Shanghai 201203, China.
Jiaxuan XiaDepartment of Pharmaceutics, School of Pharmacy, Fudan University & Key Laboratory of Smart Drug Delivery, Ministry of Education, MOE Innovative Center for New Drug Development of Immune Inflammatory Diseases, Fudan University, Shanghai 201203, China.
Ying ZhuDepartment of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Meichen DongDepartment of Pharmaceutics, School of Pharmacy, Fudan University & Key Laboratory of Smart Drug Delivery, Ministry of Education, MOE Innovative Center for New Drug Development of Immune Inflammatory Diseases, Fudan University, Shanghai 201203, China.
Jianxin WangDepartment of Pharmaceutics, School of Pharmacy, Fudan University & Key Laboratory of Smart Drug Delivery, Ministry of Education, MOE Innovative Center for New Drug Development of Immune Inflammatory Diseases, Fudan University, Shanghai 201203, China.
Fudan University · CNFudan University Shanghai Cancer Center · CN

Funding

the National Natural Science Foundation of China No.82074277the National Natural Science Foundation of China No.82374296
6 · The paper itself

Abstract

Exosomes are multifunctional, cell-derived nanoscale membrane vesicles. Exosomes derived from certain mammalian cells have been developed as angiogenesis promoters for the treatment of myocardial ischemia-reperfusion injury, as they possess the capability to enhance endothelial cell proliferation, migration, and angiogenesis. However, the low yield of exosomes derived from mammalian cells limits their clinical applications. Therefore, we chose to extract exosome-like nanoparticles from the traditional Chinese medicine

Indexed as

ExosomesMyocardial Reperfusion InjuryNanoparticlesSalvia miltiorrhizaAngiogenesisAnimalsHumansHuman Umbilical Vein Endothelial CellsMammalsTranscription FactorsTranscription Factorsangiogenesis promotersDanshen-derived exosome-like nanoparticlesexosomesmyocardial ischemia–reperfusion injury

Identifiers

PMID38611878
PMCPMC11013048
OpenAlexW4393862299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.